D-Ribose (BioDeep_00000004143)
Main id: BioDeep_00000015049
Secondary id: BioDeep_00001868469, BioDeep_00001872742
natural product human metabolite PANOMIX_OTCML-2023 Endogenous blood metabolite BioNovoGene_Lab2019
代谢物信息卡片
化学式: C5H10O5 (150.0528)
中文名称: D-(-)-核糖, D-核糖, (2R,3R,4R)-2,3,4,5-四羟基戊醛
谱图信息:
最多检出来源 Homo sapiens(blood) 27.6%
分子结构信息
SMILES: C(C1C(C(C(O1)O)O)O)O
InChI: InChI=1S/C5H10O5/c6-1-2-3(7)4(8)5(9)10-2/h2-9H,1H2
描述信息
D-Ribose, commonly referred to as simply ribose, is a five-carbon sugar found in all living cells. Ribose is not an essential nutrient because it can be synthesized by almost every tissue in the body from other substances, such as glucose. It is vital for life as a component of DNA, RNA, ATP, ADP, and AMP. In nature, small amounts of ribose can be found in ripe fruits and vegetables. Brewers yeast, which has a high concentration of RNA, is another rich source of ribose. D-ribose is also a component of many so-called energy drinks and anti-ageing products available on the market today. Ribose is a structural component of ATP, which is the primary energy source for exercising muscle. The adenosine component is an adenine base attached to the five-carbon sugar ribose. ATP provides energy to working muscles by releasing a phosphate group, hence becoming ADP, which in turn may release a phosphate group, then becoming AMP. During intense muscular activity, the total amount of ATP available is quickly depleted. In an effort to correct this imbalance, AMP is broken down in the muscle and secreted from the cell. Once the breakdown products of AMP are released from the cell, the energy potential (TAN pool) of the muscle is reduced and ATP must then be reformed using ribose. Ribose helps restore the level of adenine nucleotides by bypassing the rate-limiting step in the de novo (oxidative pentose phosphate) pathway, which regenerates phosphoribosyl pyrophosphate (PRPP), the essential precursor for ATP. If ribose is not readily available to a cell, glucose may be converted to ribose. Ribose supplementation has been shown to increase the rate of ATP resynthesis following intense exercise. The use of ribose in men with severe coronary artery disease resulted in improved exercise tolerance. Hence, there is interest in the potential of ribose supplements to boost muscular performance in athletic activities (PMID: 17618002, Curr Sports Med Rep. 2007 Jul;6(4):254-7.).
Ribose, also known as D-ribose or alpha-delta-ribose-5, is a member of the class of compounds known as pentoses. Pentoses are monosaccharides in which the carbohydrate moiety contains five carbon atoms. Ribose is very soluble (in water) and a very weakly acidic compound (based on its pKa). Ribose can be found in a number of food items such as lemon verbena, devilfish, watercress, and chicory roots, which makes ribose a potential biomarker for the consumption of these food products. Ribose can be found primarily in most biofluids, including urine, cerebrospinal fluid (CSF), saliva, and feces, as well as throughout most human tissues. Ribose exists in all living species, ranging from bacteria to humans. In humans, ribose is involved in the pentose phosphate pathway. Ribose is also involved in few metabolic disorders, which include glucose-6-phosphate dehydrogenase deficiency, ribose-5-phosphate isomerase deficiency, and transaldolase deficiency. Moreover, ribose is found to be associated with ribose-5-phosphate isomerase deficiency. The ribose β-D-ribofuranose forms part of the backbone of RNA. It is related to deoxyribose, which is found in DNA. Phosphorylated derivatives of ribose such as ATP and NADH play central roles in metabolism. cAMP and cGMP, formed from ATP and GTP, serve as secondary messengers in some signalling pathways .
D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].
D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].
D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[1].
同义名列表
16 个代谢物同义名
(3R,4S,5R)-5-(Hydroxymethyl)tetrahydrofuran-2,3,4-triol; (3R,4S,5R)-5-(hydroxymethyl)oxolane-2,3,4-triol; β-D-ribofuranose; D-Ribofuranoside; D-Ribofuranose; Ribofuranoside; D-Ribofuranose; pentofuranose; D-(-)-Ribose; Ribofuranose; D-Ribose; Ribose; D-Ribose; D-Ribose; (2R,3R,4R)-2,3,4,5-tetrahydroxypentanal; D-Ribose(mixture of isomers)
数据库引用编号
34 个数据库交叉引用编号
- ChEBI: CHEBI:111514
- ChEBI: CHEBI:47013
- KEGG: C00121
- PubChem: 5779
- PubChem: 993
- HMDB: HMDB0000283
- Metlin: METLIN313
- ChEMBL: CHEMBL444125
- Wikipedia: Ribose
- MetaCyc: |D-Ribofuranose|
- KNApSAcK: C00034198
- foodb: FDB031292
- chemspider: 5575
- CAS: 292853-79-3
- CAS: 15761-67-8
- CAS: 41546-26-3
- CAS: 83379-40-2
- CAS: 613-83-2
- CAS: 50-69-1
- MoNA: PS019702
- MoNA: PS019703
- MoNA: PS019701
- PMhub: MS000015907
- PubChem: 3421
- PDB-CCD: BDR
- PDB-CCD: RIB
- 3DMET: B04636
- NIKKAJI: J60.867J
- medchemexpress: HY-W018772
- LOTUS: LTS0019607
- wikidata: Q179271
- BioNovoGene_Lab2019: BioNovoGene_Lab2019-557
- BioNovoGene_Lab2019: BioNovoGene_Lab2019-736
- KNApSAcK: 47013
分类词条
相关代谢途径
BioCyc(6)
PlantCyc(0)
代谢反应
162 个相关的代谢反应过程信息。
Reactome(51)
- Metabolism:
2MACA-CoA + CoA ⟶ Ac-CoA + PROP-CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
ATP + R5P ⟶ AMP + PRPP
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Carbohydrate metabolism:
L-gulonate + NAD ⟶ 3-dehydro-L-gulonate + H+ + NADH
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
ATP + PROP-CoA + carbon dioxide ⟶ ADP + MEMA-CoA + Pi
- Carbohydrate metabolism:
H2O + Heparan(3)-PGs ⟶ CH3COO- + Heparan(4)-PGs
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
L-gulonate + NAD ⟶ 3-dehydro-L-gulonate + H+ + NADH
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
2MACA-CoA + CoA ⟶ Ac-CoA + PROP-CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
2MACA-CoA + CoA ⟶ Ac-CoA + PROP-CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
ATP + R5P ⟶ AMP + PRPP
- Metabolism:
2MACA-CoA + CoA ⟶ Ac-CoA + PROP-CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
CAR + propionyl CoA ⟶ CoA-SH + Propionylcarnitine
- Carbohydrate metabolism:
ATP + PYR + carbon dioxide ⟶ ADP + OAA + Pi
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
GAA + SAM ⟶ CRET + H+ + SAH
- Carbohydrate metabolism:
ATP + PYR + carbon dioxide ⟶ ADP + OAA + Pi
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
ATP + PROP-CoA + carbon dioxide ⟶ ADP + MEMA-CoA + Pi
- Carbohydrate metabolism:
ATP + PYR + carbon dioxide ⟶ ADP + OAA + Pi
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
ATP + R5P ⟶ AMP + PRPP
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Carbohydrate metabolism:
D-glucuronate + H+ + TPNH ⟶ L-gulonate + TPN
- Pentose phosphate pathway:
PDG + TPN ⟶ H+ + RU5P + TPNH + carbon dioxide
BioCyc(71)
- adenosine nucleotides degradation I:
H2O + inosine ⟶ D-ribofuranose + hypoxanthine
- purine nucleotides degradation I (plants):
H2O + inosine ⟶ D-ribofuranose + hypoxanthine
- superpathway of purines degradation in plants:
H2O + inosine ⟶ D-ribofuranose + hypoxanthine
- adenosine nucleotides degradation I:
H2O + inosine ⟶ D-ribofuranose + hypoxanthine
- superpathway of purines degradation in plants:
H2O + O2 + urate ⟶ 5-hydroxyisourate + hydrogen peroxide
- adenosine nucleotides degradation I:
H2O + xanthosine ⟶ D-ribofuranose + xanthine
- purine nucleotides degradation I (plants):
H2O + xanthosine ⟶ D-ribofuranose + xanthine
- ribose phosphorylation:
ATP + D-ribofuranose ⟶ ADP + D-ribofuranose 5-phosphate + H+
- ribose phosphorylation:
ATP + D-ribofuranose ⟶ ADP + D-ribofuranose 5-phosphate + H+
- superpathway of pyrimidine ribonucleosides salvage:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine ribonucleosides salvage II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- superpathway of pyrimidine ribonucleosides salvage:
ATP + cytidine ⟶ ADP + CMP + H+
- pyrimidine ribonucleosides salvage II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine ribonucleosides degradation II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine salvage pathway:
H2O + uridine ⟶ D-ribofuranose + uracil
- pyrimidine ribonucleosides salvage II:
H2O + uridine ⟶ D-ribofuranose + uracil
- pyrimidine ribonucleosides salvage II:
H2O + uridine ⟶ D-ribofuranose + uracil
- pyrimidine ribonucleosides salvage II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine ribonucleosides salvage II:
H2O + uridine ⟶ D-ribofuranose + uracil
- purine and pyrimidine metabolism:
AMP + diphosphate ⟶ PRPP + adenine
- pyrimidine ribonucleosides salvage II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine ribonucleosides salvage II:
H+ + H2O + cytidine ⟶ ammonium + uridine
- guanosine nucleotides degradation I:
H2O + xanthosine ⟶ D-ribofuranose + xanthine
- pyrimidine ribonucleosides salvage III:
H+ + H2O + cytosine ⟶ ammonium + uracil
- pyrimidine ribonucleosides salvage III:
H2O + cytidine ⟶ D-ribofuranose + cytosine
- pyrimidine ribonucleosides salvage III:
H2O + cytidine ⟶ D-ribofuranose + cytosine
- salvage pathways of pyrimidine ribonucleotides:
GTP + cytidine ⟶ CMP + GDP + H+
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- purine nucleosides salvage II (plant):
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
H2O + adenosine ⟶ D-ribofuranose + adenine
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
H2O + adenosine ⟶ D-ribofuranose + adenine
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
AMP + diphosphate ⟶ PRPP + adenine
- adenine and adenosine salvage II:
H2O + adenosine ⟶ D-ribofuranose + adenine
- caffeine biosynthesis I:
SAM + theobromine ⟶ H+ + SAH + caffeine
- caffeine biosynthesis II (via paraxanthine):
SAM + paraxanthine ⟶ H+ + SAH + caffeine
- theobromine biosynthesis I:
7-methylxanthine + SAM ⟶ H+ + SAH + theobromine
- pyridine nucleotide cycling (plants):
1-(β-D ribofuranosyl)nicotinamide + H2O ⟶ D-ribofuranose + H+ + nicotinamide
- nicotinamide riboside salvage pathway II:
1-(β-D ribofuranosyl)nicotinamide + H2O ⟶ D-ribofuranose + H+ + nicotinamide
- pyridine nucleotide cycling (plants):
1-(β-D ribofuranosyl)nicotinamide + H2O ⟶ D-ribofuranose + H+ + nicotinamide
- guanine and guanosine salvage II:
GMP + diphosphate ⟶ PRPP + guanine
- superpathway of guanosine nucleotides degradation (plants):
H+ + H2O + guanine ⟶ ammonium + xanthine
- guanosine nucleotides degradation II:
H+ + H2O + guanine ⟶ ammonium + xanthine
- guanosine nucleotides degradation II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
GMP + diphosphate ⟶ PRPP + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanosine nucleotides degradation II:
H+ + H2O + guanine ⟶ ammonium + xanthine
- superpathway of guanosine nucleotides degradation (plants):
H2O + xanthosine ⟶ D-ribofuranose + xanthine
- guanosine nucleotides degradation II:
H+ + H2O + guanine ⟶ ammonium + xanthine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
- guanosine nucleotides degradation I:
H+ + H2O + guanosine ⟶ ammonium + xanthosine
- guanosine nucleotides degradation I:
H2O + xanthosine ⟶ D-ribofuranose + xanthine
- ribose phosphorylation:
ATP + D-ribofuranose ⟶ ADP + D-ribofuranose 5-phosphate + H+
- cis-zeatin biosynthesis:
cis-zeatin riboside + H2O ⟶ cis-zeatin + D-ribofuranose
- cis-zeatin biosynthesis:
cis-zeatin riboside + H2O ⟶ cis-zeatin + D-ribofuranose
- ribose degradation:
α-D-ribofuranose + ATP ⟶ ADP + D-ribose 5-phosphate + H+
- ribose degradation:
α-D-ribofuranose + ATP ⟶ α-D-ribose 5-phosphate + ADP + H+
- ribose degradation:
α-D-ribofuranose ⟶ β-D-ribofuranose
- adenine and adenosine salvage II:
H2O + adenosine ⟶ D-ribofuranose + adenine
- guanine and guanosine salvage II:
H2O + guanosine ⟶ D-ribofuranose + guanine
WikiPathways(0)
Plant Reactome(6)
- Metabolism and regulation:
ATP + CoA + propionate ⟶ AMP + PPi + PROP-CoA
- Hormone signaling, transport, and metabolism:
3-oxo-2-(cis-2'-pentenyl)-cyclopentane-1-octanoate + Oxygen ⟶ CH3COO- + jasmonic acid
- Trans-zeatin biosynthesis:
AMP + DMAPP ⟶ PPi + isopentenyladenosine-5'-monophosphate
- Growth and developmental processes:
AMP + DMAPP ⟶ PPi + isopentenyladenosine-5'-monophosphate
- Vegetative structure development:
AMP + DMAPP ⟶ PPi + isopentenyladenosine-5'-monophosphate
- Regulation of leaf development:
AMP + DMAPP ⟶ PPi + isopentenyladenosine-5'-monophosphate
INOH(1)
- Pentose phosphate cycle ( Pentose phosphate cycle ):
ATP + D-Ribose 5-phosphate ⟶ AMP + D-5-Phospho-ribosyl 1-diphosphate
PlantCyc(10)
- superpathway of purines degradation in plants:
H2O + O2 + urate ⟶ (S)-5-hydroxyisourate + hydrogen peroxide
- superpathway of purines degradation in plants:
H2O + O2 + urate ⟶ (S)-5-hydroxyisourate + hydrogen peroxide
- purine nucleotides degradation I (plants):
H+ + H2O + guanine ⟶ ammonium + xanthine
- superpathway of pyrimidine ribonucleosides salvage:
ATP + cytidine ⟶ ADP + CMP + H+
- superpathway of pyrimidine ribonucleosides salvage:
H+ + H2O + cytidine ⟶ ammonium + uridine
- pyrimidine salvage pathway:
H2O + UMP ⟶ phosphate + uridine
- pyrimidine salvage pathway:
H2O + UMP ⟶ phosphate + uridine
- purine nucleosides salvage II (plant):
H2O + adenosine ⟶ D-ribofuranose + adenine
- pyridine nucleotide cycling (plants):
1-(β-D ribofuranosyl)nicotinamide + H2O ⟶ D-ribofuranose + H+ + nicotinamide
- superpathway of guanosine nucleotides degradation (plants):
H+ + H2O + guanine ⟶ ammonium + xanthine
COVID-19 Disease Map(0)
PathBank(23)
- AMP Degradation (Hypoxanthine Route):
Adenosine monophosphate + Hydrogen Ion + Water ⟶ Ammonium + Inosinic acid
- Arsenate Detoxification:
Dimethylarsinate + Hydrogen Ion + reduced electron acceptor ⟶ Dimethylarsinous acid + Water + oxidized electron acceptor
- cis-Zeatin-O-Glucoside Biosynthesis:
Water + cis-zeatin riboside ⟶ Cis-zeatin + D-ribofuranose
- cis-Zeatin-N-Glucoside Biosynthesis:
Water + cis-zeatin riboside ⟶ Cis-zeatin + D-ribofuranose
- NAD Metabolism:
N'-Formylkynurenine + Water ⟶ Formic acid + Hydrogen Ion + L-Kynurenine
- Nicotinate and Nicotinamide Metabolism:
Adenosine triphosphate + L-Glutamine + Nicotinic acid adenine dinucleotide + Water ⟶ Adenosine monophosphate + L-Glutamic acid + NAD + Pyrophosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Glucose-6-phosphate Dehydrogenase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Ribose-5-phosphate Isomerase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Transaldolase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Ribose Degradation:
-D-Ribopyranose + Adenosine triphosphate + Water ⟶ -D-Ribopyranose + Adenosine diphosphate + Hydrogen Ion + Phosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Glucose-6-phosphate Dehydrogenase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Ribose-5-phosphate Isomerase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Transaldolase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Pentose Phosphate Pathway:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Glucose-6-phosphate Dehydrogenase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Ribose-5-phosphate Isomerase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Transaldolase Deficiency:
Adenosine triphosphate + D-Ribose 5-phosphate ⟶ Adenosine monophosphate + Phosphoribosyl pyrophosphate
- Ribose Degradation:
-D-Ribopyranose + Adenosine triphosphate + Water ⟶ -D-Ribopyranose + Adenosine diphosphate + Hydrogen Ion + Phosphate
PharmGKB(0)
3 个相关的物种来源信息
- 9606 - Homo sapiens: -
- 2096 - Mycoplasma gallisepticum: 10.1128/MSYSTEMS.00055-17
- 3677 - Trichosanthes Kirilowii Maxim: -
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Biswas Gopa, Jagatkumar Bhatt, Kovur G Hemavathi. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.
Indian journal of pharmacology.
2012 Mar; 44(2):238-42. doi:
10.4103/0253-7613.93857
. [PMID: 22529483] - Hong Zhu, Yunbo Li. NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.
Cardiovascular toxicology.
2012 Mar; 12(1):39-45. doi:
10.1007/s12012-011-9136-9
. [PMID: 21818552] - Yukihiro Yoshimura, Nobuhiro Zaima, Tatsuya Moriyama, Yukio Kawamura. Different localization patterns of anthocyanin species in the pericarp of black rice revealed by imaging mass spectrometry.
PloS one.
2012; 7(2):e31285. doi:
10.1371/journal.pone.0031285
. [PMID: 22363605] - J Vasantha, P Soundararajan, N Vanitharani, G Kannan, P Thennarasu, G Neenu, C Umamaheswara Reddy. Safety and efficacy of nicotinamide in the management of hyperphosphatemia in patients on hemodialysis.
Indian journal of nephrology.
2011 Oct; 21(4):245-9. doi:
10.4103/0971-4065.83735
. [PMID: 22022084] - Elena Synesiou, Lynnette D Fairbanks, H Anne Simmonds, Ewa M Slominska, Ryszard T Smolenski, Elizabeth A Carrey. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?.
Toxins.
2011 06; 3(6):520-37. doi:
10.3390/toxins3060520
. [PMID: 22069723] - Maja Jakesevic, Kjersti Aaby, Grethe-Iren A Borge, Bengt Jeppsson, Siv Ahrné, Göran Molin. Antioxidative protection of dietary bilberry, chokeberry and Lactobacillus plantarum HEAL19 in mice subjected to intestinal oxidative stress by ischemia-reperfusion.
BMC complementary and alternative medicine.
2011 Jan; 11(?):8. doi:
10.1186/1472-6882-11-8
. [PMID: 21272305] - Huawen Lin, Alan L Kwan, Susan K Dutcher. Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii.
PLoS genetics.
2010 Sep; 6(9):e1001105. doi:
10.1371/journal.pgen.1001105
. [PMID: 20838591] - Chia-Chuan Chang, Angela Fay Ku, Yun-Yu Tseng, Wen-Bin Yang, Jim-Min Fang, Chi-Huey Wong. 6,8-Di-C-glycosyl flavonoids from Dendrobium huoshanense.
Journal of natural products.
2010 Feb; 73(2):229-32. doi:
10.1021/np900252f
. [PMID: 20055483] - Riko Katahira, Hiroshi Ashihara. Profiles of the biosynthesis and metabolism of pyridine nucleotides in potatoes (Solanum tuberosum L.).
Planta.
2009 Dec; 231(1):35-45. doi:
10.1007/s00425-009-1023-2
. [PMID: 19820966] - Kentaro Ohyama, Hidefumi Shinohara, Mari Ogawa-Ohnishi, Yoshikatsu Matsubayashi. A glycopeptide regulating stem cell fate in Arabidopsis thaliana.
Nature chemical biology.
2009 Aug; 5(8):578-80. doi:
10.1038/nchembio.182
. [PMID: 19525968] - P Vyskocilová, P Hornik, D Friedecký, P Frycák, K Lemr, T Adam. Synthesis and mass spectrometric fragmentation characteristics of imidazole ribosides-analogs of intermediates of purine de novo synthetic pathway.
Nucleosides, nucleotides & nucleic acids.
2006; 25(9-11):1237-40. doi:
10.1080/15257770600894691
. [PMID: 17065098] - William L Nyhan. Disorders of purine and pyrimidine metabolism.
Molecular genetics and metabolism.
2005 Sep; 86(1-2):25-33. doi:
10.1016/j.ymgme.2005.07.027
. [PMID: 16176880] - Gang-Liang Huang, Xin-Ya Mei, Man-Xi Liu, Tian-Cai Liu. Synthesis, (1-->3)-beta-D-glucanase-binding ability and phytoalexin-elicitor activity of (R)-2,3-epoxypropyl (1-->3)-beta-D-pentaglucoside.
Bioorganic & medicinal chemistry letters.
2004 Dec; 14(24):6027-9. doi:
10.1016/j.bmcl.2004.09.076
. [PMID: 15546722] - Xiaojun Wang, Rose Wang, Thomas A Nemcek, Ning Cao, Jeffrey Y Pan, Ernst U Frevert. A self-contained 48-well fatty acid oxidation assay.
Assay and drug development technologies.
2004 Feb; 2(1):63-9. doi:
10.1089/154065804322966324
. [PMID: 15090211] - Christian Andersen, Elke Maier, Gabrielle Kemmer, Julia Blass, Anna-Karina Hilpert, Roland Benz, Joachim Reidl. Porin OmpP2 of Haemophilus influenzae shows specificity for nicotinamide-derived nucleotide substrates.
The Journal of biological chemistry.
2003 Jul; 278(27):24269-76. doi:
10.1074/jbc.m213087200
. [PMID: 12695515] - J Schmidt-Brauns, M Herbert, G Kemmer, A Kraiss, S Schlör, J Reidl. Is a NAD pyrophosphatase activity necessary for Haemophilus influenzae type b multiplication in the blood stream?.
International journal of medical microbiology : IJMM.
2001 Aug; 291(3):219-25. doi:
10.1078/1438-4221-00122
. [PMID: 11554562] - L Giuliani, G Carmignani, E Belgrano, P Puppo. Transcatheter arterial embolization in urological tumors: the use of isobutyl-2-cyanoacrylate.
The Journal of urology.
1979 May; 121(5):630-4. doi:
10.1016/s0022-5347(17)56913-x
. [PMID: 439260] - A Puigvert, D Ruano. [Etiopathogenesis of so-called congenital hydronephrosis].
Journal d'urologie et de nephrologie.
1979 Jan; 85(1-2):1-12. doi:
NULL
. [PMID: 439196] - U Burchardt, R J Haschen, H Krosch. Clinical usefulness of enzyme determinations in urine.
Current problems in clinical biochemistry.
1979; ?(9):106-12. doi:
NULL
. [PMID: 446066] - G C Varnam, M K Jeacock, D A Shepherd. Activities of ketone body utilising enzymes in tissues of fed and fasted sheep.
Research in veterinary science.
1978 Jan; 24(1):124-5. doi:
10.1016/s0034-5288(18)33113-8
. [PMID: 24243] - A C Buck. Disorders of micturition in bacterial prostatitis.
Proceedings of the Royal Society of Medicine.
1975 Aug; 68(8):508-11. doi:
NULL
. [PMID: 681]